Toward an understanding of tissue factor pathway inhibitor-2 as a novel serodiagnostic marker for clear cell carcinoma of the ovary.

Published in: The journal of obstetrics and gynaecology research (2021)

Serum TFPI-2 reflects the overexpression of TFPI-2 in CCC tissues and is a potential serodiagnostic marker. Further research is needed to explore the expression, clinical significance, biological function, and potential mechanism of TFPI-2 in CCC.

Keyphrases

poor prognosis
gene expression
human health
transcription factor
risk assessment
long non coding rna
climate change